SCHEMBL7523337

SCHEMBL7523337

CCCCNc1ccc2c3c(cccc13)C(=O)N(CCN)C2=O

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.84
MEN1 O00255 5/20 0.84
USP2 O75604 3/20 0.84
ATM Q13315 2/20 0.84
MAPT P10636 2/20 0.84
HTT P42858 2/20 0.84
MAPK1 P28482 2/20 0.84
L3MBTL1 Q9Y468 2/20 0.84
TLR9 Q9NR96 2/20 0.84
POLB P06746 2/20 0.84
RGS12 O14924 1/20 0.84
NPSR1 Q6W5P4 1/20 0.84
TDP1 Q9NUW8 1/20 0.84
DYRK3 O43781 1/20 0.72
RPS6KB1 P23443 1/20 0.72
EPHA2 P29317 1/20 0.72
FLT4 P35916 1/20 0.72
CSNK2A1 P68400 1/20 0.72
HDAC1 Q13547 3/20 0.62
HDAC6 Q9UBN7 3/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29460431 0.91 KMT2A (1.00) KMT2AMEN1USP2ATMMAPT
SCHEMBL372370 0.91 KMT2A (1.00) KMT2AMEN1USP2ATMMAPT
SCHEMBL1580102 0.91 KMT2A (0.84) KMT2AMEN1USP2ATMMAPT
SCHEMBL28087595 0.90 KMT2A (0.83) KMT2AMEN1USP2ATMMAPT
SCHEMBL14817850 0.89 KMT2A (0.74) KMT2AMEN1USP2ATMMAPT
SCHEMBL9386920 0.88 KMT2A (0.77) KMT2AMEN1USP2ATMMAPT
SCHEMBL3886877 0.88 KMT2A (0.77) KMT2AMEN1USP2ATMMAPT
SCHEMBL1505179 0.88 KMT2A (0.88) KMT2AMEN1USP2ATMMAPT
SCHEMBL14817833 0.87 KMT2A (0.82) KMT2AMEN1USP2ATMMAPT
SCHEMBL19718354 0.87 KMT2A (0.86) KMT2AMEN1USP2ATMMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020119581-A1 Detection of analytes SENSORS FOR MEDICINE AND SCIENCE, INC. 2002-08-29 US disclosed
US-20020094586-A1 Detection of analytes SENSORS FOR MEDICINE AND SCIENCE, INC. (US) 2002-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020094586-A1 Detection of analytes AKR7A2, DDX6, ANXA6 KMT2A 3818/4885MEN1 2877/4885USP2 1026/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.